Skip to main content
. 2019 May 22;4(9):1235–1247. doi: 10.1016/j.ekir.2019.05.010

Figure 3.

Figure 3

Mean (SD) weekly hemoglobin level (g/dl) (a) and mean (SD) weekly epoetin dose by body weight (BW; U/kg/week) (b) during the maintenance phase. Analyses were performed on the intent-to-treat (ITT) population. Over the 16-week maintenance phase, there was no difference between groups in mean weekly hemoglobin (P = 0.8) or mean weekly epoetin dose/kg BW (P = 0.7).